Protective effects of L-type fatty acid-binding protein (L-FABP) in proximal tubular cells against glomerular injury in anti-GBM antibody-mediated glomerulonephritis

Nephrology Dialysis Transplantation

Volumn 26, Issue 11, 2011, Pages 3465-3473

  Kanaguchi, Yasuhiko ^a   Suzuki, Yusuke ^a   Osaki, Ken ^a   Sugaya, Takeshi ^a   Horikoshi, Satoshi ^a   Tomino, Yasuhiko ^a  

^a JUNTENDO UNIVERSITY   (Japan)

Author keywords

L FABP; oxidative stress; tubulointerstitial damage

Indexed keywords

4 HYDROXYNONENAL; ALPHA SMOOTH MUSCLE ACTIN; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BIOLOGICAL MARKER; FATTY ACID BINDING PROTEIN; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; LIVER TYPE FATTY ACID BINDING PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN KIM 1; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CELL PROTECTION; CELL SWELLING; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GLOMERULONEPHRITIS; HISTOPATHOLOGY; KIDNEY FIBROSIS; KIDNEY GLOMERULAR INJURY; KIDNEY INJURY; KIDNEY TUBULE CELL; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; PROTEINURIA; THROMBOSIS; TRANSGENIC MOUSE; WILD TYPE;

ALDEHYDES; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANIMALS; AUTOANTIBODIES; BLOTTING, WESTERN; CHEMOKINE CCL2; CYSTEINE PROTEINASE INHIBITORS; CYTOKINES; FATTY ACID-BINDING PROTEINS; FATTY ACIDS, NONESTERIFIED; FEMALE; GLOMERULONEPHRITIS; HUMANS; INFLAMMATION; KIDNEY TUBULES, PROXIMAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, TRANSGENIC; NEPHRITIS, INTERSTITIAL; OXIDATIVE STRESS; PPAR GAMMA; PROTEINURIA; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL RATE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80155136385     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr110     Document Type: Article

References (47)

1. Remuzzi G, Bertani T. Pathophysiology of progressive nephropathies. N Engl J Med 1998; 339: 1448-1456
2. Remuzzi G, Ruggenenti P, Benigni A. Understanding the nature of renal disease progression. Kidney Int 1997; 51: 2-15
3. Peterson JC, Adler S, Humsicker LG et al. Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Intern Med 1995; 123: 754-762
4. Eddy AA. Experimental insights into the tubulointerstitial disease accompanying primary glomerular lesions. J Am Soc Nephrol 1994; 5: 1273-1287
5. Eddy AA, McCulloch L, Adams J et al. A relationship between proteinuria and acute tubulointerstitial disease in rats with experimental nephritic syndrome. Am J Pathol 1991; 138: 1111-1123
6. Kamijo-Ikemori A, Sugaya T, Kimura K et al. Liver-type fatty acidbinding protein attenuates renal injury induced by unilateral ureteral obstruction. Am J Pathol 2006; 169: 1107-1117
7. Negishi K, Noiri E, Fujita T et al. Renal L-type fatty acid-binding protein mediates the bezafibrate reduction of cisplatin-induced acute kidney injury. Kidney Int 2008; 73: 1374-1384
8. NegishiK,Noiri E, SugayaTet al.Arole of liver fatty acid-binding protein in cisplatin-induced acute renal failure. Kidney Int 2007; 72: 348-358
9. Wang G, Gong Y, Burczynski FJ et al. Antioxidative function of L-FABP in L-FABP stably transfected Chang liver cells. Hepatology 2006; 42: 871-879
10. AriciM, Chana R, Brunskill NJ et al. Stimulation of proximal tubular cell apoptosis by albumin-bound fatty acids mediated by peroxisome proliferator activated receptor-gamma. J Am Soc Nephrol 2003; 14: 17-27
11. Thomas ME, Morrison AR, Schreiner GF. Metabolic effects of fatty acid-bearing albumin on a proximal tubule cell line. Am J Physiol 1995; 268: F1177-1184
12. Thomas ME, Schreiner GF. Contribution of proteinuria to progressive renal injury: Consequences of tubular uptake of fatty acid bearing albumin. Am J Nephrol 1993; 13: 385-398
13. Kees-Folts D, Sadow JL, Schreiner GF. Tubular catabolism of albumin is associated with the release of an inflammatory lipid. Kidney Int 1994; 45: 1697-1709
14. Veerkamp JH, van Kuppevelt TH, Prinsen CF et al. Structural and functional aspects of cytosolic fatty acid-binding proteins. Prostaglandins Leukot Essent Fatty Acids 1993; 49: 887-906
15. Veerkamp JH, Peeters RA, Maatman RG. Structural and functional features of different types of cytoplasmic fatty acid-binding proteins. Biochim Biophys Acta 1991; 1081: 1-24
16. Sweetser DA, Heuckeroth RO, Gordon JI. The metabolic significance of mammalian fatty-acid-binding proteins: Abundant proteins in search of a function. Annu Rev Nutr 1987; 7: 337-359
17. Ek-Von Mentzer BA, Zhang F, Hamilton JA. Binding of 13-HODE and 15-HETE to phospholipid bilayers, albumin, and intracellular fatty acid binding proteins. Implications for transmembrane and intracellular transport and for protection from lipid peroxidation. J Biol Chem 2001; 276: 15575-15580
18. Raza H, Pongubala JR, Sorof S. Specific high affinity binding of lipoxygenase metabolites of arachidonic acid by liver fatty acid binding protein. Biochem Biophys Res Commun 1989; 161: 448-455
19. Yamamoto T, Noiri E, Sugaya T et al. Renal L-type fatty acid- binding protein in acute ischemic injury. J Am Soc Nephrol 2007; 18: 2894-2902
20. Nakamura T, Sugaya T, Koide H. Urinary liver-type fatty acidbinding protein levels for differential diagnosis of idiopathic focal glomerulosclerosis and minor glomerular abnormalities and effect of low-density lipoprotein apheresis. Clin Nephrol 2006; 65: 1-6
21. Kamijo A, Kimura K, Omata M et al. Urinary fatty acid-binding protein as a new clinical marker of the progression of chronic renal disease. J Lab Clin Med 2004; 143: 23-30
22. Ferguson MA, Vaidya VS, Waikar SS et al. Urinary liver-type fatty acid-binding protein predicts adverse outcomes in acute kidney injury. Kidney Int 2010; 77: 708-714
23. Kamijo A, Sugaya T, Kimura K et al. Urinary excretion of fatty acidbinding protein reflects stress overload on the proximal tubules. Am J Pathol 2004; 165: 1243-1255
24. Nangaku M. Mechanisms of tubulointerstitial injury in the kidney: Final common pathways to end-stage renal failure. Intern Med 2004; 43: 9-17
25. Zuo N, Suzuki Y, Sugaya T et al. Protective effects of tubular livertype fatty acid-binding protein against glomerular damage in murine IgA nephropathy. Nephrol Dial Transplant. (in press)
26. Assman KJ, Tangelder MM, Lange WP et al. Anti-GBM nephritis in the mouse: Severe proteinuria in the heterologous phase. Virchows Arch A Pathol Anat Histopathol 1985; 406: 285-299
27. Suzuki Y, Shirato I, Tomino Y et al. Distinct contribution of Fc receptors and angiotensin II-dependent pathways in anti-GBM glomerulonephritis. Kidney Int 1998; 54: 1166-1174
28. Tanabe Y, Morikawa Y, Nakayama K. Effects of olmesartan, an AT1 receptor antagonist, on hypoxia-induced activation of ERK1/2 and pro-inflammatory signals in the mouse lung. Naunyn-Schmiedebergs Arch Pharmacol 2006; 374: 235-248
29. Wong MG, Suzuki Y, Tomino Y et al. Peritubular ischemia contributes more to tubular damage than proteinuria in immune-mediated glomerulonephritis. J Am Soc Nephrol 2008; 19: 290-297
30. Wilson CB. Immune models of glomerular injury. In: Neilson EG, Couser WG, eds. Immunologic Renal Diseases. Philadelphia, PA: Lippincott-Raven Publishers; 1997: 729-773
31. Suzuki Y, Gómez-guerrero C, Egido J et al. Pre-existing glomerular immune complexes induce polymorphonuclear cell recruitment through an Fc receptor-dependent respiratory burst: Potential role in the perpetuation of immune nephritis. J Immunol 2003; 170: 3243-3253
32. Suzuki Y, Gómez-guerrero C, Egido J et al. Susceptibility to T cellmediated injury in immune complex disease is linked to local activation of renin-angiotensin system: The role of NF-AT pathway. J Immunol 2002; 169: 4136-4146
33. Hidaka T, Suzuki Y, Tomino Y et al. Amelioration of crescentic glomerulonephritis by RhoA kinase inhibitor, Fasudil, through podocyte protection and prevention of leukocyte migration. Am J Pathol 2008; 172: 603-614
34. Sasaki H, Kamijo-Ikemori A, Sugaya T et al. Urinary fatty acids and liver-type fatty acid binding protein in diabetic nephropathy. Nephron Clin Pract 2009; 112: C148-c156
35. Lindner A, Hinds TR, Joly A et al. Neutral lipid from proteinuric rat urine is a novel inhibitor of the red blood cell calcium pump. J Am Soc Nephrol 1999; 10: 1170-1178
36. Maatman RG, van de Westerlo EM, van Kuppevelt TH et al. Molecular identification of the liver- and the heart-type fatty acid-binding proteins in human and rat kidney. Use of the reverse transcriptase polymerase chain reaction. Biochem J 1992; 288: 285-290
37. Atshaves BP, McIntosh AM, Lyuksyutova OI et al. Liver fatty acidbinding protein gene ablation inhibits branched-chain fatty acid metabolism in cultured primary hepatocytes. J Biol Chem 2004; 279: 30954-30965
38. Erol E, Kumar LS, Cline GW et al. Liver fatty acid binding protein is required for high rates of hepatic fatty acid oxidation but not for the action of PPARalpha in fasting mice. FASEB J 2004; 18: 347-349
39. Fels LM, Sanz-Altamira PM, Stolte H et al. Filtration characteristics of the single isolated perfused glomerulus of Myxine glutinosa. Ren Physiol Biochem 1993; 16: 276-284
40. Suzuki Y, Ruiz-Prtega M, Egido J et al. Inflammation and angiotensin II. Int J Biochem Cell Biol 2003; 35: 881-900
41. Kamijo-Ikemori A, Sugaya T, Kimura K. Urinary fatty acid binding protein in renal disease. Clin Chim Acta 2006; 374: 1-7
42. Kamijo-Ikemori A, Sugaya T, Kimura K et al. Amelioration of diabetic tubulointerstitial damage in liver-type fatty acid binding protein transgenic mice. Nephrol Dial Transplant 2009; 24: 788-800
43. Ravetch JV. Fc receptors: Rubor redux. Cell 1994; 78: 553-560
44. Sylvestre DL, Ravetch JV. Fc receptors initiate the Arthus reaction: Redefining the inflammatory cascade. Science 1994; 265: 1095-1098
45. Boyce NW, Holdsworth SR. Anti-glomerular basement membrane antibody-induced experimental glomerulonephritis: Evidence for dose-dependent, direct antibody and complement-induced, cell-independent injury. J Immunol 1985; 135: 3918-3921
46. Schrijver G, Schalkwijk J, Koene RA et al. Antiglomerular basement membrane nephritis in beige mice. Deficiency of leukocytic neutral proteinases prevents the induction of albuminuria in the heterologous phase. J Exp Med 1989; 1: 1435-1448
47. Boyce NW, Holdsworth SR. Intrarenal hemodynamic alterations induced by anti-GBM antibody. Kidney Int 1987; 31: 8-14